COVID-19: consider cytokine storm syndromes and immunosuppression
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med
Ramos-Casals, 2014, Adult haemophagocytic syndrome, Lancet, 383, 1503, 10.1016/S0140-6736(13)61048-X
Karakike, 2019, Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis, Front Immunol, 10, 55, 10.3389/fimmu.2019.00055
Seguin, 2016, Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis, Chest, 149, 1294, 10.1016/j.chest.2015.11.004
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5
Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2
Shakoory, 2016, Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial, Crit Care Med, 44, 275, 10.1097/CCM.0000000000001402
Richardson, 2020, Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet, 395, e30, 10.1016/S0140-6736(20)30304-4